Inhaled transmembrane ion transport modulators and non-steroidal anti-inflammatory drugs in asthma

Thorax

Volumn 55, Issue SUPPL. 2, 2000, Pages

  Bianco, S ^a   Robuschi, M ^a   Vaghi, A ^b   Fumagalli, A ^a   Sestini, P ^c  

^a SAN GERARDO HOSPITAL   (Italy)

^b Ospedale di Garbagnate   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; CAPSAICIN; CHROMONE DERIVATIVE; CITRIC ACID; FUROSEMIDE; LOOP DIURETIC AGENT; LYSINE ACETYLSALICYLATE; METHACHOLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PIRETANIDE; PROSTAGLANDIN SYNTHASE;

ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CONFERENCE PAPER; COUGHING; ENZYME INHIBITION; HUMAN; ION TRANSPORT; MEMBRANE TRANSPORT; PRIORITY JOURNAL;

ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; ETHANOL; FUROSEMIDE; HUMANS; ION TRANSPORT;

EID: 0033807649     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. 1 Bianco S, Robuschi M, Sestini P, et al. Osmolarity, bronchial reactivity, and the protective effect of loop diuretics. In: Melillo G, Norman PS, Marone G, eds. Respiratory allergy. Toronto: BC Decker, 1990: 119-30.
2. 2 Bianco S, Robuschi M, Vaghi A, et al. Airway ion transport mechanisms and aspirin in asthma. In: Szczeklick A, Gryglewski RJ, Vane RV, eds. Eicosanoids, aspirin, and asthma. New York: Marcel Dekker, 1998: 419-38.
3. 2O) bronchoconstriction. Pulm Pharmacol 1989;1:187-91.
4. 4 Bianco S, Pieroni M, Refini R, et al. Inhaled loop diuretics as potential new anti-asthmatic drugs. Eur Respir J 1993, 6:130-4.
5. 5 Bianco S, Pieroni MG, Refini RM, et al. Protective effect of inhaled loop diuretics on experimentally induced bronchoconstriction. In: Spector SH, ed. Provocation resting in clinical practice. New York: Marcel Dekker, 1995: 411-23.
6. 6 Pavord ID, Wisniewski A, Tattersfield AE. Inhaled frusemide and exercise-induced asthma: evidence of a role for inhibiting prostanoids. Thorax 1992; 47:797-800
7. 7 Bianco S, Vaghi A, Pieroni MG, et al. Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acctylsalicylate. Allergy 1993; 48:570-5.
8. 8 Vaghi A, De Bernardi G, Sestini P, et al. Effect of inhaled lysine-aspirin on the protective activity of bumetanide against ultrasonically nebulized water. Eur Respir J 1996;9(Suppl 23):33s.
9. 9 Grassi N, Vaghi A, DeBernardi G. et al. Effect of inhaled lysine aspirin on the protective activity of torasemide against ultrasonically nebulized distilled water. Eur Respir J 1999;14(Suppl 30):530s
10. 10 Rodwell LT, Anderson SD, Spring J, et al. Effect of inhaled frusemide and oral indomethacin on the airway response to hypertonic saline challenge in asthmatic subjects. Thorax 1997;52:59-66.
11. 11 Szcezklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999;104:5-13
12. 12 Bianco S, Pieroni MG, Refini RM, et al. Could NSAIDs have a role as antiasthmatic agents? Drugs 1994;48:9-15.
13. 13 Sestini P, Refini RM, Pieroni MG, et al. Different effects of inhaled aspirin-like drugs on allergen-induced early and late asthmatic responses. Am J Respir Crit Care Med, 1999; 159:1229-33.
14. 14 Bianco S, Robuschi M, Simone P, et al. Tolerance of carprofen in patients with asthma caused by non-steroidal anti-inflammatory drugs. J Int Med Res 1985;13:294-9.
15. 15 Bianco S, Robuschi M, Petrigni G, et al. Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin. Drugs 1993;46(Suppl 1):115-20.
16. 16 Vaghi A, Debernardi G, Grassi N, et al. Tolerance of the COX-2 inhibitor, meloxicam, in aspirin-sensitive asthmatics. Eur Respir J 1997;10:476s.
17. 17 Romanin Chr, Reinsprecht M, Pecht I, et al. The antiallergic drug cromolyn is a potent blocker of C1 channel activity in rat mucosal mast cells (RBL-2H3 line). Nayun Sch Arch Pharmacol 1991;343:313
18. 18 Sestini P, Robuschi M, Vaghi A, et al. Effect of inhaled lysine acetylsalicylate on the protective activity of cromolyn sodium against the bronchial obstructive response to ultrasonically nebulized water. Am Rev Respir Dis 1993;147: 836A.
19. 10 Berkowitz H, Reichel J, Shim C. The effect of ethanol on the cough reflex. Clin Sci Mol Med 1973;45:527-31.
20. 20 Hobbs WR, Rall TW, Verdoorn TA. Hypnotics and sedatives:ethanol. In: Goodman & Gillman 's pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996: 361-96.
21. 21 Fumagalli A, Busia A, Vernocchi S, et al. Effect of ethanol on citric acid induced cough. Eur Respir J 1999;14(Suppl 30): 533s.
22. 22 Fumagalli A, Bianchi A, Turati A, et al. Effect of inhaled ethanol on capsaicin-induced cough. Am J Respir Crit Care Med 1999;159:A534.
23. 23 Fumagalli A, Busia A, Pieroni MG, et al. Effect of ethanol on bronchoconstriction induced by ultrasonically nebulized distilled water. Eur Respir J 1999;14(Suppl 30):532s.
24. 24 Bianchi A, Molteni LP, Fumagalli A, et al. Prevention of exercise-induced asthma by inhaled ethanol. Eur Respir J 1999;14(Suppl 30):532-3s
25. 25 Grassi N, Vaghi A, DeBernardi G, et al. Effect of inhaled ethanol on hypertonic saline-induced bronchoconstriction. Eur Respir J 1999;14(Suppl 30):532s.
26. 26 Fumagalli A, Bianchi A, Vernocchi S, et al. Effect of ethanol on methacholine-induced bronchoconstriction. Eur Respir J 1999;14(Suppl 30):532s.